RETProto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors-Reference-Cited by-同舟云学术

RETProto-Oncogene: A Review and Update of Genotype–Phenotype Correlations in Hereditary Medullary Thyroid Cancer and Associated Endocrine Tumors

Published:2005-06 Issue:6 Volume:15 Page:531-544
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kouvaraki Maria A.¹,Shapiro Suzanne E.¹,Perrier Nancy D.¹,Cote Gilbert J.²,Gagel Robert F.²,Hoff Ana O.²,Sherman Steven I.²,Lee Jeffrey E.¹,Evans Douglas B.¹

Affiliation:

1. Departments of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

2. Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2005.15.531

Reference145 articles.

1. MEDULLARY (SOLID) CARCINOMA OF THE THYROID—A CLINICOPATHOLOGIC ENTITY*

2. Cancer Statistics, 2004

3. Medullary thyroid carcinoma

4. Prognostic factors for thyroid carcinoma

5. Clinical Characteristics Distinguishing Hereditary From Sporadic Medullary Thyroid Carcinoma

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness;Journal of the Endocrine Society;2024-04-06

2. Correlation of Genomic Profile with Clinicopathologic Factors and Oncologic Outcomes in Medullary Thyroid Carcinoma: Results of an International Multicenter Study;Clinical Thyroidology®;2024-04-01

3. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14

4. Targeting RET mutation in medullary thyroid cancer;Pharmacogenomics;2024-02

5. Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs);Cytotherapy;2024-01